SlideShare a Scribd company logo
Himanshu Yadav (201408006)
M Pharm.(Pharmacology)
SGT University
Parkinson's disease (PD)
 Parkinson's disease (PD) results primarily from the
death of dopaminergic neurons in the substantia
nigra.
IN VIVO MODELS
 Tremorine And Oxotremorine Antagonism
 MPTP Model In Monkeys
 Reserpine Antagonism
 Circling Behavior In Nigostriatal Lesioned Rats
 Elevated Body Swing Method
 Skilled Paw Reaching In Rats
 Stepping test in rats
IN VITRO METHODS
 1.Experiment using rat striatal slices
 2.Dopamine stimulated adenyl cyclase activity
 3.Radioligand binding studies for D1 & D2 dopamine
receptors
 4.Dopamine release from synaptosome.
 5. In vitro neuroprotective efficacy.
1.TREMORINE AND
OXOTREMORINE ANTAGONISM:
PURPOSE AND RATIONALE
 The muscarinic agonists tremorine and oxotremorine
induce parkinsonism-like signs such as tremor, ataxia,
spasticity, salivation, lacrimation and hypothermia.
 These signs are antagonized by central anticholinergic
drugs.
PROCEDURE
 Group of 6-10 male NMRI mice (Swiss-type mouse, Naval
Medical Research Institute). (18-22g)
 Dosed orally with test/ standard (5mg/kg benzatropine
mesilate) 1h prior administration of 0.5mg/kg
oxotremorine (S.C)
 Before administration of oxotremorine (S.C) rectal
temperature is measured & taken as basal value.
 Rectal temperature is again measured after 1,2,3h after
oxotremorine inj.
 Tremor is scored after oxotremorine dosage at 10 sec
observation duration for every 15min interval for 1h and
scored.
Salivation and Lacrimation are also scored every15min and 30min after
oxotremorine inj.
SCORES ARE RECORDED AS FOLLOWS:
TREMOR, SALIVATION &
LACRIMATION SCORE
Absent 0
Slight 1
Medium 2
Severe 3
Test drug & standard should reduce the score.
CRITICAL ASSESSMENT OF THE
METHOD
 The oxotremorine antagonism has been proven to be a
reliable method for testing central anticholinergic
activity.
 The overt isomorphism between the animal model and
the symptoms of Parkinson’s disease recommend this
test for screening of anti-Parkinson drugs.
 However, the model measures only central
anticholinergic activity & cannot be used to screen
dopaminergic drugs.
2. Reserpine antagonism
 PURPOSE AND RATIONALE
 Reserpine induces depletion of central catecholamine
stores.
 The sedative effect can be observed in mice shortly
after injection, followed by signs of eyelid ptosis,
hypokinesia, rigidity, catatonia, and immobility. These
phenomena can be antagonized by dopamine agonists.
 PURPOSE AND RATIONALE
 Reserpine induces depletion of central catecholamine
stores.
 The sedative effect can be observed in mice shortly
after injection, followed by signs of eyelid ptosis,
hypokinesia, rigidity, catatonia, and immobility. These
phenomena can be antagonized by dopamine agonists.
EVALUATION
 Locomotor activity and rearing & grooming scores of
drug treated animals are compared with controls
treated with reserpine and vehicle only by analysis of
variance.
 Locomotor activity of drug treated group must be
more than reserpine treated control.
3.MPTP model in monkeys
 PURPOSE AND RATIONALE
 N-MPTP (N-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine)
 It has been shown to cause symptoms of Parkinson’s
disease in exposed individuals. When administered to
primates(monkeys as in this case) this compound
causes a partial destruction of basal ganglia (by ETC
blockade) and a syndrome that resembles Parkinson’s
disease.
4.Circling behavior in
nigrostriatal lesioned rats
 PURPOSE AND RATIONALE
 Unilateral lesion of the dopaminergic nigrostriatal pathway in
the rat by the neurotoxin 6-hydroxydopamine (6OHDA) induces
hypersensitivity of the postsynaptic dopaminergic receptors in
the striatum of the lesioned side. The rats rotate in a circling
chamber in a direction towards the lesioned side (ipsilateral)
when an indirect acting compound such as amphetamine is
administered.
 But to the opposite direction (contralateral) when a direct acting
dopamine agonist, e.g., apomorphine, or the dopamine precursor
L-dopa is given. Therefore, this test can be used for the study of
central dopamine function and the evaluation of dopamine
antagonists and agonists, particularly the activity of novel
antiparkinsonian drugs.
5. Elevated body
swing test
 PURPOSE AND RATIONALE
 Borlongan and Sanberg (1995) proposed the elevated body
swing test as a measure of asymmetrical motor behavior of
parkinsonian animals in a drug-free state.
 The total number of swings made to each side is divided by
the overall total number of swings made to both sides to
get percentages of left and right swings. The criterion of
biased swing is set at 70% or higher.
 6-OHDA-lesioned rats exhibit right biased swings of 70%
or higher compared to normal rats.
PURPOSE AND RATIONALE
 The term “staircase test” mentioned in this context, has nothing to do with
the staircase test for evaluating anxiolytic activity in rats.
 Unilateral injection of 6-OHDA into the medial forebrain bundle results in
an impairment of paw reaching on both sides which can be ameliorated by
drug treatment or transplantation of a nigral cell suspension.
 The number of Saccharin pellets eaten during the test period indicates the
rat’s success in grasping and retrieving the pellets; the number of steps from
which pellets have been removed provides an index of the attempts to reach
the food and how far the rat can reach; the number of missed pellets
remaining at the end of the test on the floor of the side compartment
indicates a lack of sensorimotor coordination in grasping and retrieving the
pellets
 The apparatus has been developed after earlier studies of motor cortex,
nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the
rat which is impaired in PD.
IN VITRO METHODS
1.EXPERIMENT USING RAT STAITAL SLICES
2. DOPAMINE STUMILATED ADENYLY CYCLASE
ACTIVITY
Screening model for MS
 Invitro Methods –
 Microglia
 Oligodendrocytes
 Astrocytes
 Invivo Methods -
 The experimental autoimmune/allergic encephalomyelitis (EAE)
 Viral induced models, mainly Theiler's murine encephalomyelitis virus
(TMEV) infection and consequential chronic demyelination.
 Toxin-induced models of demyelination, such as the cuprizone and the lyso-
phosphatidylcholine (lysolecithin) mod
In vivo Methods
The experimental autoimmune/allergic encephalomyelitis (EAE)
 The most-studied animal model of MS is the experimental
autoimmune encephalomyelitis (EAE), in which autoimmunity to CNS
components is induced in susceptible mice through immunization
with self-antigens derived from basic myelin protein.
 EAE may be induced in mice with different genetic backgrounds, such
as SJL/J, C57BL/6 and NOD, through either active immunization with
protein or peptide, or by passive transfer of encephalitogenic T cells.
 The relevant immunogen is derived from self-CNS proteins such as
myelin basic protein (MBP), proteolipid protein (PLP) or myelin
oligodendrocyte glycoprotein (MOG).
Procedure
 Active EAE relies on CNS reactive T cell that are induced following
immunization by an auto antigen.
 Emulsified in an adjuvant , EAE is induced by transferring auto reactive T cell
to recipient animal .
 Adjuvants which are used contains killed mycobacteria that elicit T cell
responses as well as antibody production due to innate immune activation .
 Immunization of SJL/J mice with the immunodominant epitope of PLP
(PLP139–151) induces a relapsing–remitting (RR) disease course, while disease
induced by the immunodominant MOG(35–55) peptide in C57BL6/J mice is of
chronic nature .
 MOG(35–55) was able to induce direct CNS autoimmunity, and
accompanied administration of pertussis toxin (PT) was able to
enhance disease onset and severity.
 Pathogenesis of EAE

 Substantial evidence from MS subjects indicates that CD8+ T
cells play a key role in the pathogenesis of the disease .CD8+T
cells have been found more represent than CD4+T cells in acute
and chronic CNS lesions of MS patients.
 EAE in mice is characterized by an ascending paralysis beginning
at the tail followed by limb and forelimb paralysis, assessed by
using a 5-points scale.
 MOG(35–55) was able to induce direct CNS autoimmunity,
and accompanied administration of pertussis toxin (PT)
was able to enhance disease onset and severity.
 Pathogenesis of EAE

 Substantial evidence from MS subjects indicates that CD8+
T cells play a key role in the pathogenesis of the disease
.CD8+T cells have been found more represent than CD4+T
cells in acute and chronic CNS lesions of MS patients.
 EAE in mice is characterized by an ascending paralysis
beginning at the tail followed by limb and forelimb
paralysis, assessed by using a 5-points scale.
 Immunotherapies specifically targeting CD4+ T cells failed to
show significant clinical benefit in MS course, whereas therapies
that affect all leukocytes can improve disease progression.
 Theiler's murine encephalomyelitis virus (TMEV) infection
 Viral infections of the CNS can induce demyelination in mice
and the best studied are the picornavirus, such as Theiler's
murine encephalomyelitis virus (TMEV).
 TMEV is divided into two subgroups, based on the ability to
cause disease in the CNS :-
 GDVII
 TO
 GDVII subgroup - Highly neurovirulent for mice, as it induces death within 1
to 2 weeks. GDVII virus predominantly infects neurons and dying neurons
display chromatin condensation and apoptotic (fragmented) nuclei
(karyorrhexis).
 TO subgroup -- The DA and BeAn strains of the TO subgroup induce acute
polioencephalomyelitis.
 In TMEV infection, axonal damage precedes demyelination (inside-out model)
and the distribution of damaged axons observed during the early phase
corresponds to regions, where subsequent inflammatory demyelination occurs
during the chronic phase .

 Toxin-induced models of MS
 Two most common agents utilized to induce demyelination are
 Cuprizone
 Lysolecithin.
 Cuprizone (biscyclohexanone-oxaldihydrazone) is a copper chelating reagent which,
supplemented to normal rodent chow, causes oligodendroglial cell death with
subsequent demyelination, together with a profound activation of astrocytes and
microglia.
 Specific targets of cuprizone in mice are mature oligodendrocytes, which fail to fulfill the
extensive metabolic demand and consequently undergo apoptosis, while the other cell
types are not

 affected. The main reason for the metabolic failure is copper
deficiency due to the copper chelation properties of cuprizone.
 Lysolecithin is an activator of phospholipase A2 which induces
focal areas of demyelination upon injection into the spinal cord
in several animals, including cat, rabbit, rat and mouse.
 Demyelination occurs due to primary toxic effects of detergent
on myelin sheaths, rather than to secondary effects on
oligodendrocytes.
 Infiltration and activation of macrophages and microglia begin
within hours after injection and last many days.
References
1) Parkinson's disease: mechanisms and models
2) William Dauer 1, Serge Przedborski
3) Viral models of multiple sclerosis:
neurodegeneration and demyelination in mice
infected with Theiler's virus
4) Miriam Mecha 1, Francisco J Carrillo-Salinas, Leyre
Mestre, Ana Feliú, Carmen Guaza

More Related Content

What's hot

Screening models on aphrodisiac agents
Screening models on aphrodisiac agentsScreening models on aphrodisiac agents
Screening models on aphrodisiac agents
Jaineel Dharod
 
Pharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agentsPharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agents
Abin Joy
 
Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.
S.G.S.S. COLLEGE OF PHARMACY, MANUR
 
Screening Model of Anti-diarrheal activity.pptx
Screening Model of Anti-diarrheal activity.pptxScreening Model of Anti-diarrheal activity.pptx
Screening Model of Anti-diarrheal activity.pptx
RushikeshTidake
 
pre clinical Screening for anti asthmatic drugs
pre clinical Screening  for anti asthmatic drugspre clinical Screening  for anti asthmatic drugs
pre clinical Screening for anti asthmatic drugs
DHINESHKUMAR V
 
Preclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulantsPreclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulants
Rashmi116
 
Multiple sclerosis screening methods
Multiple sclerosis screening methodsMultiple sclerosis screening methods
Multiple sclerosis screening methods
mohamed abusalih
 
Screening Models of Antidepressants Drugs
Screening Models of Antidepressants DrugsScreening Models of Antidepressants Drugs
Screening Models of Antidepressants Drugs
KomalSingh301
 
Preclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer'sPreclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer's
Drx Burade
 
Alternative animal experimentation technique
Alternative animal experimentation techniqueAlternative animal experimentation technique
Alternative animal experimentation technique
KARNATAKA COLLEGE OF PHARMACY
 
Extrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxExtrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptx
ARSHIKHANAM4
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Abdul Hameed
 
screening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugsscreening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugs
borude123
 
Anti-diarrhoeal screening models and methods
Anti-diarrhoeal screening models and methodsAnti-diarrhoeal screening models and methods
Anti-diarrhoeal screening models and methods
Pervej Alom
 
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
Drx Burade
 
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIASCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
SreyaRathnaj
 
Limitations of animal models part 1
Limitations of animal models part 1  Limitations of animal models part 1
Limitations of animal models part 1
Manohar Kuppala
 
Screening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-convertedScreening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-converted
B V V S Hanagal Shri Kumareshwar College of Pharmacy, Bagalkote
 
Screening of anti emetics drug
Screening of anti emetics drugScreening of anti emetics drug
Screening of anti emetics drug
Rajeshwar Yadav
 
Screening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory DrugsScreening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory Drugs
Anupam dubey
 

What's hot (20)

Screening models on aphrodisiac agents
Screening models on aphrodisiac agentsScreening models on aphrodisiac agents
Screening models on aphrodisiac agents
 
Pharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agentsPharmacological screening of Anti-psychotic agents
Pharmacological screening of Anti-psychotic agents
 
Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.Screening of Diuretics M.PHARM PHARMACOLOGY.
Screening of Diuretics M.PHARM PHARMACOLOGY.
 
Screening Model of Anti-diarrheal activity.pptx
Screening Model of Anti-diarrheal activity.pptxScreening Model of Anti-diarrheal activity.pptx
Screening Model of Anti-diarrheal activity.pptx
 
pre clinical Screening for anti asthmatic drugs
pre clinical Screening  for anti asthmatic drugspre clinical Screening  for anti asthmatic drugs
pre clinical Screening for anti asthmatic drugs
 
Preclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulantsPreclinical screening methods of cns stimulants
Preclinical screening methods of cns stimulants
 
Multiple sclerosis screening methods
Multiple sclerosis screening methodsMultiple sclerosis screening methods
Multiple sclerosis screening methods
 
Screening Models of Antidepressants Drugs
Screening Models of Antidepressants DrugsScreening Models of Antidepressants Drugs
Screening Models of Antidepressants Drugs
 
Preclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer'sPreclinical Screening for Alzheimer's
Preclinical Screening for Alzheimer's
 
Alternative animal experimentation technique
Alternative animal experimentation techniqueAlternative animal experimentation technique
Alternative animal experimentation technique
 
Extrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptxExtrapolation of in vitro data to preclinical and.pptx
Extrapolation of in vitro data to preclinical and.pptx
 
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEEDScreening model of antidiarrheal activity Presented by ABDUL HAMEED
Screening model of antidiarrheal activity Presented by ABDUL HAMEED
 
screening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugsscreening methodes of anti-diabetic drugs
screening methodes of anti-diabetic drugs
 
Anti-diarrhoeal screening models and methods
Anti-diarrhoeal screening models and methodsAnti-diarrhoeal screening models and methods
Anti-diarrhoeal screening models and methods
 
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
Preclinical Screening for Neurodegenerative Disease (Parkinsonism)
 
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIASCREENING OF DRUGS USED IN ANTIARRYTHMIA
SCREENING OF DRUGS USED IN ANTIARRYTHMIA
 
Limitations of animal models part 1
Limitations of animal models part 1  Limitations of animal models part 1
Limitations of animal models part 1
 
Screening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-convertedScreening models of anti psychotic drugs-converted
Screening models of anti psychotic drugs-converted
 
Screening of anti emetics drug
Screening of anti emetics drugScreening of anti emetics drug
Screening of anti emetics drug
 
Screening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory DrugsScreening Models of Anti-Inflammatory Drugs
Screening Models of Anti-Inflammatory Drugs
 

Similar to Screening models for Parkinson & multiple sclerosis

Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
SONALPANDE5
 
IN-VIVO SCREENING METHODS FOR NEURODEGENERATIVE DISEASE.pptx
IN-VIVO SCREENING METHODS FOR NEURODEGENERATIVE DISEASE.pptxIN-VIVO SCREENING METHODS FOR NEURODEGENERATIVE DISEASE.pptx
IN-VIVO SCREENING METHODS FOR NEURODEGENERATIVE DISEASE.pptx
GautamSosa
 
anti parkinson screening model .pptx
anti parkinson  screening model    .pptxanti parkinson  screening model    .pptx
anti parkinson screening model .pptx
NittalVekaria
 
Pre clinical screening of anti epileptic drugs
Pre clinical screening of anti epileptic drugsPre clinical screening of anti epileptic drugs
Pre clinical screening of anti epileptic drugs
HinnaHamid1
 
Preclinical study of anti parkinsonian drugs
Preclinical study of anti  parkinsonian drugsPreclinical study of anti  parkinsonian drugs
Preclinical study of anti parkinsonian drugs
HinnaHamid1
 
Inestrosa idn 2011
Inestrosa idn 2011Inestrosa idn 2011
Inestrosa idn 2011Jorge Parodi
 
Inestrosa idn 2011
Inestrosa idn 2011Inestrosa idn 2011
Inestrosa idn 2011Jorge Parodi
 
INVESTIGATION THE EFFECT OF PENTHYLENTETRAZOLE INDUCING EPILEPSY MODEL USING ...
INVESTIGATION THE EFFECT OF PENTHYLENTETRAZOLE INDUCING EPILEPSY MODEL USING ...INVESTIGATION THE EFFECT OF PENTHYLENTETRAZOLE INDUCING EPILEPSY MODEL USING ...
INVESTIGATION THE EFFECT OF PENTHYLENTETRAZOLE INDUCING EPILEPSY MODEL USING ...
Self-employed researcher
 
Poster Monterey 2005
Poster Monterey 2005Poster Monterey 2005
Poster Monterey 2005Anna Öberg
 
Tuberous Sclerosis - Orrin Devinsky, MD
Tuberous Sclerosis - Orrin Devinsky, MDTuberous Sclerosis - Orrin Devinsky, MD
Tuberous Sclerosis - Orrin Devinsky, MD
NYU FACES
 
NEURODEGENERATIVE DISEASE
NEURODEGENERATIVE DISEASENEURODEGENERATIVE DISEASE
NEURODEGENERATIVE DISEASE
ANAND SAGAR TIWARI
 
Bio se en_2008_1+bareme
Bio se en_2008_1+baremeBio se en_2008_1+bareme
Bio se en_2008_1+bareme
Lara El Feghali
 
Tauopathy and its therapeutic targets
Tauopathy and its therapeutic targetsTauopathy and its therapeutic targets
Tauopathy and its therapeutic targets
Pranav Sopory
 
Dietary Administration of Diquat for 13 Weeks Does Not Result in a Loss of Do...
Dietary Administration of Diquat for 13 Weeks Does Not Result in a Loss of Do...Dietary Administration of Diquat for 13 Weeks Does Not Result in a Loss of Do...
Dietary Administration of Diquat for 13 Weeks Does Not Result in a Loss of Do...
EPL, Inc.
 
piracetam and vinpocetine ameliorate rotenone induced parkinsonism in rats.
piracetam and vinpocetine ameliorate  rotenone induced parkinsonism in rats.piracetam and vinpocetine ameliorate  rotenone induced parkinsonism in rats.
piracetam and vinpocetine ameliorate rotenone induced parkinsonism in rats.
SANJAY YADAV
 
Epilepsy and anaesthesia
Epilepsy and anaesthesiaEpilepsy and anaesthesia
Epilepsy and anaesthesia
Dhritiman Chakrabarti
 
Journal presentation on essential tremor
Journal presentation on essential tremorJournal presentation on essential tremor
Journal presentation on essential tremor
Ejaj Ahmed
 

Similar to Screening models for Parkinson & multiple sclerosis (20)

Screening of antiparkinson agent
Screening of antiparkinson agentScreening of antiparkinson agent
Screening of antiparkinson agent
 
IN-VIVO SCREENING METHODS FOR NEURODEGENERATIVE DISEASE.pptx
IN-VIVO SCREENING METHODS FOR NEURODEGENERATIVE DISEASE.pptxIN-VIVO SCREENING METHODS FOR NEURODEGENERATIVE DISEASE.pptx
IN-VIVO SCREENING METHODS FOR NEURODEGENERATIVE DISEASE.pptx
 
anti parkinson screening model .pptx
anti parkinson  screening model    .pptxanti parkinson  screening model    .pptx
anti parkinson screening model .pptx
 
Pre clinical screening of anti epileptic drugs
Pre clinical screening of anti epileptic drugsPre clinical screening of anti epileptic drugs
Pre clinical screening of anti epileptic drugs
 
Publication
PublicationPublication
Publication
 
Preclinical study of anti parkinsonian drugs
Preclinical study of anti  parkinsonian drugsPreclinical study of anti  parkinsonian drugs
Preclinical study of anti parkinsonian drugs
 
Inestrosa idn 2011
Inestrosa idn 2011Inestrosa idn 2011
Inestrosa idn 2011
 
Inestrosa idn 2011
Inestrosa idn 2011Inestrosa idn 2011
Inestrosa idn 2011
 
INVESTIGATION THE EFFECT OF PENTHYLENTETRAZOLE INDUCING EPILEPSY MODEL USING ...
INVESTIGATION THE EFFECT OF PENTHYLENTETRAZOLE INDUCING EPILEPSY MODEL USING ...INVESTIGATION THE EFFECT OF PENTHYLENTETRAZOLE INDUCING EPILEPSY MODEL USING ...
INVESTIGATION THE EFFECT OF PENTHYLENTETRAZOLE INDUCING EPILEPSY MODEL USING ...
 
Poster Monterey 2005
Poster Monterey 2005Poster Monterey 2005
Poster Monterey 2005
 
Tuberous Sclerosis - Orrin Devinsky, MD
Tuberous Sclerosis - Orrin Devinsky, MDTuberous Sclerosis - Orrin Devinsky, MD
Tuberous Sclerosis - Orrin Devinsky, MD
 
Tryptophan and madness
Tryptophan and madnessTryptophan and madness
Tryptophan and madness
 
NEURODEGENERATIVE DISEASE
NEURODEGENERATIVE DISEASENEURODEGENERATIVE DISEASE
NEURODEGENERATIVE DISEASE
 
Bio se en_2008_1+bareme
Bio se en_2008_1+baremeBio se en_2008_1+bareme
Bio se en_2008_1+bareme
 
Tauopathy and its therapeutic targets
Tauopathy and its therapeutic targetsTauopathy and its therapeutic targets
Tauopathy and its therapeutic targets
 
4640-63316-1-PB
4640-63316-1-PB4640-63316-1-PB
4640-63316-1-PB
 
Dietary Administration of Diquat for 13 Weeks Does Not Result in a Loss of Do...
Dietary Administration of Diquat for 13 Weeks Does Not Result in a Loss of Do...Dietary Administration of Diquat for 13 Weeks Does Not Result in a Loss of Do...
Dietary Administration of Diquat for 13 Weeks Does Not Result in a Loss of Do...
 
piracetam and vinpocetine ameliorate rotenone induced parkinsonism in rats.
piracetam and vinpocetine ameliorate  rotenone induced parkinsonism in rats.piracetam and vinpocetine ameliorate  rotenone induced parkinsonism in rats.
piracetam and vinpocetine ameliorate rotenone induced parkinsonism in rats.
 
Epilepsy and anaesthesia
Epilepsy and anaesthesiaEpilepsy and anaesthesia
Epilepsy and anaesthesia
 
Journal presentation on essential tremor
Journal presentation on essential tremorJournal presentation on essential tremor
Journal presentation on essential tremor
 

Recently uploaded

Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
sachin783648
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
NathanBaughman3
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
yusufzako14
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
IqrimaNabilatulhusni
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
muralinath2
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Sérgio Sacani
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Erdal Coalmaker
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
muralinath2
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
Health Advances
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
Scintica Instrumentation
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
Areesha Ahmad
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
Richard Gill
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
DiyaBiswas10
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
Columbia Weather Systems
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
ossaicprecious19
 
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
ssuserbfdca9
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
muralinath2
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
muralinath2
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
silvermistyshot
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
aishnasrivastava
 

Recently uploaded (20)

Comparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebratesComparative structure of adrenal gland in vertebrates
Comparative structure of adrenal gland in vertebrates
 
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
Astronomy Update- Curiosity’s exploration of Mars _ Local Briefs _ leadertele...
 
in vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptxin vitro propagation of plants lecture note.pptx
in vitro propagation of plants lecture note.pptx
 
general properties of oerganologametal.ppt
general properties of oerganologametal.pptgeneral properties of oerganologametal.ppt
general properties of oerganologametal.ppt
 
platelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptxplatelets_clotting_biogenesis.clot retractionpptx
platelets_clotting_biogenesis.clot retractionpptx
 
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...
 
Unveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdfUnveiling the Energy Potential of Marshmallow Deposits.pdf
Unveiling the Energy Potential of Marshmallow Deposits.pdf
 
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptxBody fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
Body fluids_tonicity_dehydration_hypovolemia_hypervolemia.pptx
 
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...The ASGCT Annual Meeting was packed with exciting progress in the field advan...
The ASGCT Annual Meeting was packed with exciting progress in the field advan...
 
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...
 
GBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture MediaGBSN - Microbiology (Lab 4) Culture Media
GBSN - Microbiology (Lab 4) Culture Media
 
Richard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlandsRichard's aventures in two entangled wonderlands
Richard's aventures in two entangled wonderlands
 
extra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdfextra-chromosomal-inheritance[1].pptx.pdfpdf
extra-chromosomal-inheritance[1].pptx.pdfpdf
 
Orion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWSOrion Air Quality Monitoring Systems - CWS
Orion Air Quality Monitoring Systems - CWS
 
Lab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerinLab report on liquid viscosity of glycerin
Lab report on liquid viscosity of glycerin
 
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
4. An Overview of Sugarcane White Leaf Disease in Vietnam.pdf
 
platelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptxplatelets- lifespan -Clot retraction-disorders.pptx
platelets- lifespan -Clot retraction-disorders.pptx
 
Hemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptxHemoglobin metabolism_pathophysiology.pptx
Hemoglobin metabolism_pathophysiology.pptx
 
Lateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensiveLateral Ventricles.pdf very easy good diagrams comprehensive
Lateral Ventricles.pdf very easy good diagrams comprehensive
 
Structural Classification Of Protein (SCOP)
Structural Classification Of Protein  (SCOP)Structural Classification Of Protein  (SCOP)
Structural Classification Of Protein (SCOP)
 

Screening models for Parkinson & multiple sclerosis

  • 1. Himanshu Yadav (201408006) M Pharm.(Pharmacology) SGT University
  • 2. Parkinson's disease (PD)  Parkinson's disease (PD) results primarily from the death of dopaminergic neurons in the substantia nigra.
  • 3. IN VIVO MODELS  Tremorine And Oxotremorine Antagonism  MPTP Model In Monkeys  Reserpine Antagonism  Circling Behavior In Nigostriatal Lesioned Rats  Elevated Body Swing Method  Skilled Paw Reaching In Rats  Stepping test in rats
  • 4. IN VITRO METHODS  1.Experiment using rat striatal slices  2.Dopamine stimulated adenyl cyclase activity  3.Radioligand binding studies for D1 & D2 dopamine receptors  4.Dopamine release from synaptosome.  5. In vitro neuroprotective efficacy.
  • 5. 1.TREMORINE AND OXOTREMORINE ANTAGONISM: PURPOSE AND RATIONALE  The muscarinic agonists tremorine and oxotremorine induce parkinsonism-like signs such as tremor, ataxia, spasticity, salivation, lacrimation and hypothermia.  These signs are antagonized by central anticholinergic drugs.
  • 6. PROCEDURE  Group of 6-10 male NMRI mice (Swiss-type mouse, Naval Medical Research Institute). (18-22g)  Dosed orally with test/ standard (5mg/kg benzatropine mesilate) 1h prior administration of 0.5mg/kg oxotremorine (S.C)  Before administration of oxotremorine (S.C) rectal temperature is measured & taken as basal value.  Rectal temperature is again measured after 1,2,3h after oxotremorine inj.  Tremor is scored after oxotremorine dosage at 10 sec observation duration for every 15min interval for 1h and scored.
  • 7. Salivation and Lacrimation are also scored every15min and 30min after oxotremorine inj. SCORES ARE RECORDED AS FOLLOWS: TREMOR, SALIVATION & LACRIMATION SCORE Absent 0 Slight 1 Medium 2 Severe 3 Test drug & standard should reduce the score.
  • 8. CRITICAL ASSESSMENT OF THE METHOD  The oxotremorine antagonism has been proven to be a reliable method for testing central anticholinergic activity.  The overt isomorphism between the animal model and the symptoms of Parkinson’s disease recommend this test for screening of anti-Parkinson drugs.  However, the model measures only central anticholinergic activity & cannot be used to screen dopaminergic drugs.
  • 9. 2. Reserpine antagonism  PURPOSE AND RATIONALE  Reserpine induces depletion of central catecholamine stores.  The sedative effect can be observed in mice shortly after injection, followed by signs of eyelid ptosis, hypokinesia, rigidity, catatonia, and immobility. These phenomena can be antagonized by dopamine agonists.
  • 10.  PURPOSE AND RATIONALE  Reserpine induces depletion of central catecholamine stores.  The sedative effect can be observed in mice shortly after injection, followed by signs of eyelid ptosis, hypokinesia, rigidity, catatonia, and immobility. These phenomena can be antagonized by dopamine agonists.
  • 11. EVALUATION  Locomotor activity and rearing & grooming scores of drug treated animals are compared with controls treated with reserpine and vehicle only by analysis of variance.  Locomotor activity of drug treated group must be more than reserpine treated control.
  • 12. 3.MPTP model in monkeys  PURPOSE AND RATIONALE  N-MPTP (N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)  It has been shown to cause symptoms of Parkinson’s disease in exposed individuals. When administered to primates(monkeys as in this case) this compound causes a partial destruction of basal ganglia (by ETC blockade) and a syndrome that resembles Parkinson’s disease.
  • 13. 4.Circling behavior in nigrostriatal lesioned rats  PURPOSE AND RATIONALE  Unilateral lesion of the dopaminergic nigrostriatal pathway in the rat by the neurotoxin 6-hydroxydopamine (6OHDA) induces hypersensitivity of the postsynaptic dopaminergic receptors in the striatum of the lesioned side. The rats rotate in a circling chamber in a direction towards the lesioned side (ipsilateral) when an indirect acting compound such as amphetamine is administered.  But to the opposite direction (contralateral) when a direct acting dopamine agonist, e.g., apomorphine, or the dopamine precursor L-dopa is given. Therefore, this test can be used for the study of central dopamine function and the evaluation of dopamine antagonists and agonists, particularly the activity of novel antiparkinsonian drugs.
  • 14. 5. Elevated body swing test  PURPOSE AND RATIONALE  Borlongan and Sanberg (1995) proposed the elevated body swing test as a measure of asymmetrical motor behavior of parkinsonian animals in a drug-free state.  The total number of swings made to each side is divided by the overall total number of swings made to both sides to get percentages of left and right swings. The criterion of biased swing is set at 70% or higher.  6-OHDA-lesioned rats exhibit right biased swings of 70% or higher compared to normal rats.
  • 15. PURPOSE AND RATIONALE  The term “staircase test” mentioned in this context, has nothing to do with the staircase test for evaluating anxiolytic activity in rats.  Unilateral injection of 6-OHDA into the medial forebrain bundle results in an impairment of paw reaching on both sides which can be ameliorated by drug treatment or transplantation of a nigral cell suspension.  The number of Saccharin pellets eaten during the test period indicates the rat’s success in grasping and retrieving the pellets; the number of steps from which pellets have been removed provides an index of the attempts to reach the food and how far the rat can reach; the number of missed pellets remaining at the end of the test on the floor of the side compartment indicates a lack of sensorimotor coordination in grasping and retrieving the pellets  The apparatus has been developed after earlier studies of motor cortex, nigrostriatal dopamine and caudate-putamen to skilled forelimb use in the rat which is impaired in PD.
  • 16. IN VITRO METHODS 1.EXPERIMENT USING RAT STAITAL SLICES 2. DOPAMINE STUMILATED ADENYLY CYCLASE ACTIVITY
  • 17. Screening model for MS  Invitro Methods –  Microglia  Oligodendrocytes  Astrocytes  Invivo Methods -  The experimental autoimmune/allergic encephalomyelitis (EAE)  Viral induced models, mainly Theiler's murine encephalomyelitis virus (TMEV) infection and consequential chronic demyelination.  Toxin-induced models of demyelination, such as the cuprizone and the lyso- phosphatidylcholine (lysolecithin) mod
  • 18. In vivo Methods The experimental autoimmune/allergic encephalomyelitis (EAE)  The most-studied animal model of MS is the experimental autoimmune encephalomyelitis (EAE), in which autoimmunity to CNS components is induced in susceptible mice through immunization with self-antigens derived from basic myelin protein.  EAE may be induced in mice with different genetic backgrounds, such as SJL/J, C57BL/6 and NOD, through either active immunization with protein or peptide, or by passive transfer of encephalitogenic T cells.  The relevant immunogen is derived from self-CNS proteins such as myelin basic protein (MBP), proteolipid protein (PLP) or myelin oligodendrocyte glycoprotein (MOG).
  • 19. Procedure  Active EAE relies on CNS reactive T cell that are induced following immunization by an auto antigen.  Emulsified in an adjuvant , EAE is induced by transferring auto reactive T cell to recipient animal .  Adjuvants which are used contains killed mycobacteria that elicit T cell responses as well as antibody production due to innate immune activation .  Immunization of SJL/J mice with the immunodominant epitope of PLP (PLP139–151) induces a relapsing–remitting (RR) disease course, while disease induced by the immunodominant MOG(35–55) peptide in C57BL6/J mice is of chronic nature .
  • 20.  MOG(35–55) was able to induce direct CNS autoimmunity, and accompanied administration of pertussis toxin (PT) was able to enhance disease onset and severity.  Pathogenesis of EAE   Substantial evidence from MS subjects indicates that CD8+ T cells play a key role in the pathogenesis of the disease .CD8+T cells have been found more represent than CD4+T cells in acute and chronic CNS lesions of MS patients.  EAE in mice is characterized by an ascending paralysis beginning at the tail followed by limb and forelimb paralysis, assessed by using a 5-points scale.
  • 21.  MOG(35–55) was able to induce direct CNS autoimmunity, and accompanied administration of pertussis toxin (PT) was able to enhance disease onset and severity.  Pathogenesis of EAE   Substantial evidence from MS subjects indicates that CD8+ T cells play a key role in the pathogenesis of the disease .CD8+T cells have been found more represent than CD4+T cells in acute and chronic CNS lesions of MS patients.  EAE in mice is characterized by an ascending paralysis beginning at the tail followed by limb and forelimb paralysis, assessed by using a 5-points scale.
  • 22.  Immunotherapies specifically targeting CD4+ T cells failed to show significant clinical benefit in MS course, whereas therapies that affect all leukocytes can improve disease progression.  Theiler's murine encephalomyelitis virus (TMEV) infection  Viral infections of the CNS can induce demyelination in mice and the best studied are the picornavirus, such as Theiler's murine encephalomyelitis virus (TMEV).  TMEV is divided into two subgroups, based on the ability to cause disease in the CNS :-
  • 23.  GDVII  TO  GDVII subgroup - Highly neurovirulent for mice, as it induces death within 1 to 2 weeks. GDVII virus predominantly infects neurons and dying neurons display chromatin condensation and apoptotic (fragmented) nuclei (karyorrhexis).  TO subgroup -- The DA and BeAn strains of the TO subgroup induce acute polioencephalomyelitis.  In TMEV infection, axonal damage precedes demyelination (inside-out model) and the distribution of damaged axons observed during the early phase corresponds to regions, where subsequent inflammatory demyelination occurs during the chronic phase . 
  • 24.  Toxin-induced models of MS  Two most common agents utilized to induce demyelination are  Cuprizone  Lysolecithin.  Cuprizone (biscyclohexanone-oxaldihydrazone) is a copper chelating reagent which, supplemented to normal rodent chow, causes oligodendroglial cell death with subsequent demyelination, together with a profound activation of astrocytes and microglia.  Specific targets of cuprizone in mice are mature oligodendrocytes, which fail to fulfill the extensive metabolic demand and consequently undergo apoptosis, while the other cell types are not 
  • 25.  affected. The main reason for the metabolic failure is copper deficiency due to the copper chelation properties of cuprizone.  Lysolecithin is an activator of phospholipase A2 which induces focal areas of demyelination upon injection into the spinal cord in several animals, including cat, rabbit, rat and mouse.  Demyelination occurs due to primary toxic effects of detergent on myelin sheaths, rather than to secondary effects on oligodendrocytes.  Infiltration and activation of macrophages and microglia begin within hours after injection and last many days.
  • 26. References 1) Parkinson's disease: mechanisms and models 2) William Dauer 1, Serge Przedborski 3) Viral models of multiple sclerosis: neurodegeneration and demyelination in mice infected with Theiler's virus 4) Miriam Mecha 1, Francisco J Carrillo-Salinas, Leyre Mestre, Ana Feliú, Carmen Guaza